Insulin resistance test Canada: Where and how to get tested (2026 guide)

Introduction — a shocking Canadian statistic

Insulin resistance (IR) precedes many cases of type 2 diabetes and contributes to cardiovascular risk. Recent national data show roughly 8.0% of Canadians aged 18+ reported having diabetes in 2023, with many more carrying prediabetes — a sign that insulin resistance is common and often under‑detected. This underlines the public‑health importance of knowing where and how Canadians can get tested for IR. ([www150.statcan.gc.ca](https://www150.statcan.gc.ca/n1/pub/82-570-x/82-570-x2024001-eng.pdf?utm_source=openai))

What is insulin resistance, and why does it matter?

Insulin resistance means tissues (muscle, liver, fat) respond less well to insulin, so the pancreas produces more insulin to keep blood sugar normal. Over time this compensatory hyperinsulinaemia can fail, blood glucose rises and prediabetes or type 2 diabetes develops. Detecting insulin resistance early offers a window where lifestyle interventions are most effective. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9542105/?utm_source=openai))

Tests used in Canada to assess insulin resistance and dysglycaemia

Standard screening tests (recommended by Diabetes Canada)

Diabetes Canada’s Clinical Practice Guidelines recommend using fasting plasma glucose (FPG), hemoglobin A1c (A1C) and a 75 g oral glucose tolerance test (OGTT) for screening and diagnosis. These are widely accepted by family doctors and provincial labs for identifying prediabetes and diabetes. ([guidelines.diabetes.ca](https://guidelines.diabetes.ca/health-care-provider-tools/screening-and-diagnosis-algorithm?utm_source=openai))

Fasting insulin and HOMA‑IR

HOMA‑IR (Homeostatic Model Assessment of Insulin Resistance) is a simple index calculated using fasting insulin and fasting glucose. Formula (HOMA1): HOMA‑IR = (fasting insulin [µU/mL] × fasting glucose [mmol/L]) / 22.5. This gives an estimate of insulin sensitivity and can reveal hyperinsulinaemia before A1C or fasting glucose rise. Remember: insulin assays and cut‑offs vary — use trends and clinical context rather than a single absolute number. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9542105/?utm_source=openai))

OGTT with insulin sampling

OGTT‑with‑insulin captures the dynamic insulin response and is useful for complex or equivocal cases (PCOS, atypical diabetes presentations), but it is more time‑consuming and usually performed by specialists or in research settings. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35676014/?utm_source=openai))

Other indices (TyG, QUICKI, CGM)

Indices like TyG (triglyceride × glucose) and QUICKI exist as surrogate markers; CGM is increasingly used to detect early post‑prandial dysglycaemia. Systematic reviews are refining their roles but they remain adjuncts rather than standard population screening tests. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7085845/?utm_source=openai))

How accurate and reliable are these tests?

HOMA‑IR correlates with gold‑standard clamps reasonably well at a population level but has limitations for individual diagnosis due to assay variability, differences across ethnic groups and lack of universal cut‑offs. Systematic reviews conclude HOMA‑IR is useful for research and for detecting trends clinically, but clinicians should combine it with other tests and risk factors for decision‑making. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9542105/?utm_source=openai))

Where to get tested across Canada — practical options

1. Family doctor / primary care — the usual route. They can order FPG, A1C, OGTT and fasting insulin when clinically appropriate. Publicly funded tests are usually covered when medically justified. ([guidelines.diabetes.ca](https://guidelines.diabetes.ca/getmedia/6c07d660-33a6-4cfa-abb0-e521eb4bb67d/2024-CPG-Quick-Reference-Guide_1.pdf?utm_source=openai))
2. Walk‑in clinics and community/hospital labs — accept clinician requisitions; schedules and availability vary by province and facility. ([myhealth.alberta.ca](https://myhealth.alberta.ca/Find-Health-Care/Facilities/Pages/Profile.aspx?facilityid=2&serviceid=1000871&utm_source=openai))
3. Private / DTC labs — if you need a test without wait or without a requisition, companies such as JustLabs and other private services offer fasting insulin and related panels for a fee (availability and price vary). These services ship and have collection sites across provinces. Validate units and methods before ordering. ([justlabs.health](https://justlabs.health/tests/insulin-fasting?utm_source=openai))
4. Endocrinology referral and specialist testing — for complex cases, endocrinologists can order OGTT‑with‑insulin or arrange specialized metabolic testing. ([cmaj.ca](https://www.cmaj.ca/sites/default/files/additional-assets/site/pdfs/focus_on_diabetes.pdf?utm_source=openai))

Provincial practicalities

Provincial programs differ: public lab testing requires a clinician’s requisition and is generally covered when medically necessary; private tests are available across Canada for those willing to pay. Examples include Ontario’s OHIP guidance on lab coverage and Alberta Health Services’ lab service descriptions — check your province’s health site for specifics. Many private labs operate from BC to Newfoundland, but coverage, requisition rules and turnaround times vary. ([img1.wsimg.com](https://img1.wsimg.com/blobby/go/47c78ccf-d12f-481a-82c2-f7dc3b6ca738/downloads/safofikafaxili.pdf?utm_source=openai))

Interpreting results — practical guidance

• Always confirm lab units: insulin reported as µU/mL or pmol/L (1 µU/mL ≈ 6 pmol/L). Use µU/mL with glucose in mmol/L for HOMA‑IR. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9542105/?utm_source=openai))
• There is no single universal HOMA‑IR cut‑off; studies use different thresholds (many >2–2.5 as suggestive). Serial measures and clinical context are most helpful. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC12411212/?utm_source=openai))
• Normal A1C/fasting glucose does not always exclude early insulin resistance — consider OGTT, fasting insulin/HOMA‑IR or CGM in at‑risk patients. ([diabetes.ca](https://www.diabetes.ca/health-care-providers/clinical-practice-guidelines/chapter-4?utm_source=openai))

What to do if insulin resistance is likely

1. Talk to your health provider about follow‑up testing and risk — diabetes education, dietitian referral and monitoring may be recommended. ([guidelines.diabetes.ca](https://guidelines.diabetes.ca/getmedia/6c07d660-33a6-4cfa-abb0-e521eb4bb67d/2024-CPG-Quick-Reference-Guide_1.pdf?utm_source=openai))
2. Evidence‑based lifestyle changes: moderate weight loss (5–10%), combined aerobic and resistance exercise and dietary quality (Mediterranean/DASH) reduce insulin resistance. Some intermittent fasting/time‑restricted eating protocols reduce HOMA‑IR in trials. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35371260/?utm_source=openai))
3. Medication (metformin) may be considered in high‑risk or persistent prediabetes — discuss with your clinician. Provincial coverage for medications varies. ([guidelines.diabetes.ca](https://guidelines.diabetes.ca/getmedia/6c07d660-33a6-4cfa-abb0-e521eb4bb67d/2024-CPG-Quick-Reference-Guide_1.pdf?utm_source=openai))

How Feel Great may fit into a Canadian plan

The Feel Great system combines a soluble fibre matrix (Balance) that may blunt post‑meal glucose peaks, a yerba mate extract (Unimate) rich in chlorogenic acids that has modest RCT evidence for improving HOMA‑IR and glycaemia in some groups, and a practical 4‑4‑12 time‑restricted eating protocol. Clinical trials of time‑restricted eating and yerba mate show potential to reduce fasting insulin and HOMA‑IR in at‑risk adults. These tools are supportive lifestyle options — they are not drugs and should be discussed with your provider. Check Health Canada’s LNHPD for Natural Product Numbers (NPN) before buying supplements. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35371260/?utm_source=openai))

People also ask

FAQ

References & Scientific Sources

1. Public Health Agency of Canada — Snapshot of Diabetes in Canada, 2023. ([canada.ca](https://www.canada.ca/en/public-health/services/publications/diseases-conditions/snapshot-diabetes-canada-2023.html?utm_source=openai))
2. Health Infobase — Diabetes in Canada interactive report (Health Canada / PHAC). ([health-infobase.canada.ca](https://health-infobase.canada.ca/diabetes/?utm_source=openai))
3. Statistics Canada — Diabetes among Canadian adults. ([statcan.gc.ca](https://www.statcan.gc.ca/o1/en/plus/5103-diabetes-among-canadian-adults?utm_source=openai))
4. Diabetes Canada — Clinical Practice Guidelines, Screening & Diagnosis. ([guidelines.diabetes.ca](https://guidelines.diabetes.ca/health-care-provider-tools/screening-and-diagnosis-algorithm?utm_source=openai))
5. CIHI — Diabetes outcomes, hospitalizations and equity analyses. ([cihi.ca](https://www.cihi.ca/en/equity-in-diabetes-care-a-focus-on-lower-limb-amputation/amputations-signal-opportunities-to-improve-diabetes-care-and-reduce-system-costs?utm_source=openai))
6. Measuring and estimating insulin resistance in clinical and research settings — NCBI / Endotext review. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9542105/?utm_source=openai))
7. HOMA‑IR systematic review and meta‑analysis (PubMed). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36181637/?utm_source=openai))
8. Intermittent fasting systematic review and meta‑analysis (impact on HOMA‑IR). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35371260/?utm_source=openai))
9. Yerba mate systematic review / RCT evidence (glycaemia, HOMA‑IR). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/41244043/?utm_source=openai))
10. TyG index diagnostic accuracy systematic review. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC7085845/?utm_source=openai))
11. Health Canada — Licensed Natural Health Products Database (LNHPD). ([canada.ca](https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/licensed-natural-health-products-database.html?utm_source=openai))
12. JustLabs (example Canadian DTC lab offering fasting insulin). ([justlabs.health](https://justlabs.health/tests/insulin-fasting?utm_source=openai))

Medical disclaimer: This article is informational and not a substitute for professional medical advice. Tests, interpretation and therapeutic decisions should be made with a licensed healthcare provider. For urgent concerns, contact your family doctor or local emergency services. The Feel Great system is offered as a supportive lifestyle tool and is not a medication. Check Health Canada’s LNHPD for NPNs and speak with your clinician before starting supplements. ([canada.ca](https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/applications-submissions/product-licensing/licensed-natural-health-products-database.html?utm_source=openai))